The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers

Annals of Surgical Oncology

Volumn 11, Issue 1, 2004, Pages 52-58

  Pappo, Itzhak ^a   Meirshon, Ioana ^a   Karni, Tamar ^a   Siegelmann Danielli, Nava ^a   Stahl Kent, Varda ^a   Sandbank, Judith ^a   Wasserman, Ilan ^a   Halevy, Ariel ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Breast cancer; Hormone replacement therapy; HRT; Tumor characteristics

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES;

EID: 2142743257     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1007/BF02524346     Document Type: Article

References (42)

1. DR Morrisey JT Kirchner 2000 Management of the climacteric Postgrad Med 108 85 100 10.3810/pgm.2000.07.1159
2. KM Brett JH Madans 1997 Use of postmenopausal hormone-replacement therapy: estimates from a nationally representative cohort study Am J Epidemiol 145 536 44 9063344 1:STN:280:DyaK2s3hslehsQ%3D%3D
3. T Moorhead P Hannaford M Warskyi 1997 Prevalence and characteristics associated with the use of hormone-replacement therapy in Brain Br J Obstet Gynaecol 104 290 7 9091004 1:STN:280:DyaK2s3is1amtw%3D%3D
4. B Kaplan S Aschkenazi-Steinberg Y Yogev R Nahum J Sulkes M Phisher 2002 Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause Menopause 9 354 9 12218724 10.1097/00042192-200209000- 00008 (Pubitemid 36701895)
5. DC Smith R Prentice DJ Thompson WL Hermann 1975 Association of exogenous estrogen and endometrial cancer N Engl J Med 293 1164 7 1186789 1:STN:280:DyaE28%2FltFWkug%3D%3D
6. J Marsden 2002 Hormone replacement therapy and breast cancer Lancet Oncol 3 303 11 12067808 10.1016/S1470-2045(02)00732-5 (Pubitemid 34546448)
7. DM Strickland RD Gambrell Jr CA Butzin K Strickland 1992 The relationship between breast cancer survival and prior postmenopausal estrogen use Obstet Gynecol 80 400 4 1495695 1:STN:280:DyaK38zlslegsg%3D%3D
8. JR Palmer L Rosenberg EA Clake DR Miller S Shapiro 1991 Breast cancer risk after estrogen replacement therapy: Results from the Toronto breast cancer study Am J Epidemiol 134 1386 95 1663701 1:STN:280:DyaK387jtlGrtA%3D%3D
9. C La Vecchia E Negri S Franceschi, et al. 1995 Hormone replacement treatment and breast cancer risk: a cooperative Italian study Br J Cancer 72 244 8 7599060
10. PA Newcomb MP Longnecker BE Storer, et al. 1995 Long-term hormone replacement therapy and the risk of breast cancer in postmenopausal women Am J Epidemiol 142 788 95 7572954 1:STN:280:DyaK28%2FhslCjsw%3D%3D
11. TA Sellers PJ Mink JR Cerhan, et al. 1997 The role of hormone replacement therapy in the risk of breast cancer and total mortality in women with a family history of breast cancer Ann Intern Med 127 973 80 9412302 1:CAS:528: DyaK2sXnvF2rsb0%3D
12. Collaborative Group on Hormonal Factors for Breast Cancer 1997 Breast cancer and hormone replacement therapy. Collaborative reanalysis from 51 individual epidemiological studies Lancet 350 1047 60 10.1016/S0140-6736(97) 08233-0 (Pubitemid 27437855)
13. GA Colditz SE Hankinson DJ Hunter, et al. 1995 The use of estrogens and progestins and the risk of breast cancer in postmenopausal women N Engl J Med 332 1589 93 7753136 1:STN:280:DyaK2M3nt1Knsg%3D%3D 10.1056/NEJM199506153322401
14. C Schairer J Lubin R Troisi L Brinton R Hoover 2000 Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk JAMA 283 485 91 10659874 1:CAS:528:DC%2BD3cXns1GltA%3D%3D 10.1001/jama.283.4.485
15. Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial JAMA 288 321 33 10.1001/jama.288.3.321
16. CL Chen NS Weiss P Newcomb W Barlow E White 2002 Hormone replacement therapy in relation to breast cancer JAMA 287 734 41 11851540 1:CAS:528:DC%2BD38Xht1Kktrg%3D 10.1001/jama.287.6.734
17. DB Willis EE Calle H Miracle McMahil CW Heath 1996 Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States Cancer Causes Control 7 449 57 8813433 1:STN:280:DyaK28vgvVChsw%3D%3D 10.1007/BF00052671 (Pubitemid 26228334)
18. C Harding WF Knox EB Faragher A Baildam NJ Bundred 1996 Hormone replacement therapy and tumor grade in breast cancer: prospective study in screening unit BMJ 312 1646 7 8664718 1:STN:280:DyaK283ms1yhtQ%3D%3D
19. K Holli J Isola J Cuzik 1998 Low biologic aggressiveness in breast cancer in women using hormone replacement therapy J Clin Oncol 16 3115 20 9738583 1:CAS:528:DyaK1cXmtFSlsLc%3D
20. V Sacchini S Zurrida G Andreoni, et al. 2002 Pathologic and biological prognostic factors in short- and long-term hormone replacement therapy users Ann Surg Oncol 9 266 71 11923133 10.1245/aso.2002.9.3.266 (Pubitemid 34298631)
21. Rosen PP, Oberman HA.Tumors of the Mammary Gland. Washington, DC: Armed Forces Institute of Pathology, 1993.
22. Green FL, Page DL, Fleming ID, et al. The breast. In:AJCC Cancer Staging Manual. 6th ed. Heidelberg: Springer-Verlag, 2002:221-40.
23. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer: the value of histological grade in breast cancer Histopathology 19 403 10 1757079 1:STN:280:DyaK38%2FpvVSltw%3D%3D
24. J Cheek J Lacy S Toth-Fejel K Morris C Calhoun R Pommier 2002 The impact of hormone replacement therapy on the detection and stage of breast cancer Arch Surg 137 1015 21 12215151 10.1001/archsurg.137.9.1015
25. RC Delgado DML Lopez 2001 Prognosis of breast cancer detected in women receiving hormone replacement therapy Maturitas 38 147 56 11306203 1:CAS:528:DC%2BD3MXisF2ksLs%3D 10.1016/S0378-5122(00)00213-9 (Pubitemid 32295928)
26. C Gajdos P Tartter A Babinzki 2000 Breast cancer diagnosed during hormone replacement therapy Obstet Gynecol 95 513 8 10725482 1:STN:280: DC%2BD3c7pt1Wjsw%3D%3D 10.1016/S0029-7844(99)00594-3 (Pubitemid 30139569)
27. D Merom A Ifrah I Cohen-Manheim A Chinich MS Green 2002 Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel: the National Women's Health Interview Survey, 1998 IMAJ 4 671 6 12440227
28. P Bonnier F Bessenay AJ Sasco, et al. 1998 Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast Cancer Int J Cancer 79 278 82 9645351 1:CAS:528:DyaK1cXjvF2rtLs%3D 10.1002/(SICI)1097-0215(199806)79:3<278::AID-IJC12>3.0.CO;2-5 (Pubitemid 28262214)
29. C Magnusson L Holmberg T Norden A Lindgren I Persson 1996 Prognostic characteristics in breast cancers after hormone replacement therapy Breast Cancer Res Treat 38 325 34 8739086 1:CAS:528:DyaK28Xjs1elu7Y%3D 10.1007/BF01806152 (Pubitemid 26126667)
30. CI Li NS Weiss JL Stanford JR Daling 2000 Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women Cancer 88 2570 7 10861435 1:CAS:528:DC%2BD3cXktFGjsLs%3D 10.1002/1097- 0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O (Pubitemid 30331965)
31. JR Daling KE Malone DR Doody, et al. 2002 Relation of reginens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma Cancer 95 2455 64 12467057 1:CAS:528: DC%2BD38XpslehsLY%3D 10.1002/cncr.10984 (Pubitemid 35424029)
32. SM Gapstur M Morrow TA Sellers 1999 Hormone replacement therapy and the risk of breast cancer with a favorable histology JAMA 281 2091 7 10367819 1:CAS:528:DyaK1MXktVejurY%3D 10.1001/jama.281.22.2091 (Pubitemid 29264687)
33. WA Knight RB Livingstone EJ Gregory WL McGuire 1977 Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer Cancer Res 37 4669 71 922747 1:CAS:528:DyaE1cXkvVOgsw%3D%3D
34. GN Peters T Fodera J Sabol S Jones D Euhus 2001 Estrogen replacement therapy after breast cancer: a 12-year follow-up Ann Surg Oncol 8 828 32 11776498 1:STN:280:DC%2BD38%2FkvVynug%3D%3D 10.1007/s10434-001-0828-4
35. JS Lawson AS Field DD Tran N Houssami 2001 Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women Breast Cancer Res 3 342 5 11597325 1:CAS:528: DC%2BD3MXntlegsbY%3D 10.1186/bcr318 (Pubitemid 32851166)
36. CJ Fabian BF Kimler R McKittrick, et al. 1994 Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers-a Southwest Oncology Group study Cancer Res 54 5357 62 7923165 1:STN:280: DyaK2M%2FgslGmtg%3D%3D
37. MA Cobleigh FE Norlock DM Oleske A Starr 1999 Hormone replacement therapy and high S phase in breast cancer JAMA 281 1528 30 10227323 1:STN:280:DyaK1M3ktFylsA%3D%3D 10.1001/jama.281.16.1528 (Pubitemid 29200937)
38. NE Hynes DF Stern 1994 The biology of ErbB-2/neu/HER-2 and its role in cancer Biochim Biophys Acta 1198 165 84 7819273
39. SA Chrysogelos RB Dickson 1994 EGF receptor expression, regulation and function in breast cancer Breast Cancer Res Treat 29 29 40 8018962 1:STN:280:DyaK2c3ovFOksg%3D%3D 10.1007/BF00666179
40. K Nanda LA Bastian K Schultz 2002 Hormone replacement therapy and the risk of death from breast cancer: a systematic review Am J Obstet Gynecol 186 325 34 11854659 1:CAS:528:DC%2BD38Xit1Wns7c%3D 10.1067/mob.2002.121077 (Pubitemid 34165456)
41. F Grodstein MJ Stampfer G Colditz, et al. 1997 Postmenopausal hormone therapy and mortality N Engl J Med 336 1769 76 9187066 1:CAS:528: DyaK2sXlt12isb4%3D 10.1056/NEJM199706193362501 (Pubitemid 27262172)
42. G Ursin CC Tseng Paganini-Hill, et al. 2002 Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 20 699 706 11821451 1:CAS:528:DC%2BD38XhsVGmt7w%3D 10.1200/JCO.20.3.699 (Pubitemid 34111377)